IVF Hartmann Holding AG
IVF Hartmann Holding AG Fundamental Analysis
IVF Hartmann Holding AG (VBSN.SW) shows moderate financial fundamentals with a PE ratio of 17.32, profit margin of 11.32%, and ROE of 12.16%. The company generates $0.2B in annual revenue with moderate year-over-year growth of 7.33%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze VBSN.SW's fundamental strength across five key dimensions:
Efficiency Score
WeakVBSN.SW struggles to generate sufficient returns from assets.
Valuation Score
ExcellentVBSN.SW trades at attractive valuation levels.
Growth Score
ExcellentVBSN.SW delivers strong and consistent growth momentum.
Financial Health Score
ExcellentVBSN.SW maintains a strong and stable balance sheet.
Profitability Score
WeakVBSN.SW struggles to sustain strong margins.
Key Financial Metrics
Is VBSN.SW Expensive or Cheap?
P/E Ratio
VBSN.SW trades at 17.32 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, VBSN.SW's PEG of -1.68 indicates potential undervaluation.
Price to Book
The market values IVF Hartmann Holding AG at 2.04 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 15.42 times EBITDA. This signals the market has high growth expectations.
How Well Does VBSN.SW Make Money?
Net Profit Margin
For every $100 in sales, IVF Hartmann Holding AG keeps $11.32 as profit after all expenses.
Operating Margin
Core operations generate 13.19 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $12.16 in profit for every $100 of shareholder equity.
ROA
IVF Hartmann Holding AG generates $9.33 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
IVF Hartmann Holding AG produces operating cash flow of $21.29M, showing steady but balanced cash generation.
Free Cash Flow
IVF Hartmann Holding AG generates strong free cash flow of $17.58M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $7.38 in free cash annually.
FCF Yield
VBSN.SW converts 5.64% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
17.32
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-1.68
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.04
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.94
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.009
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.34
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.13
vs 25 benchmark
How VBSN.SW Stacks Against Its Sector Peers
| Metric | VBSN.SW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 17.32 | 29.88 | Better (Cheaper) |
| ROE | 12.16% | 682.00% | Weak |
| Net Margin | 11.32% | -46037.00% (disorted) | Strong |
| Debt/Equity | 0.01 | 0.42 | Strong (Low Leverage) |
| Current Ratio | 4.34 | 4.49 | Strong Liquidity |
| ROA | 9.33% | -16420.00% (disorted) | Weak |
VBSN.SW outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews IVF Hartmann Holding AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
13.87%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
65.09%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
12.01%
Industry Style: Defensive, Growth, Innovation
High Growth